Search Results

then Oliver has worked at the University of Geneva, where his research on peptide engineering and GPCR pharmacology

Terry Hébert is a Professor within the Department of Pharmacology & Therapeutics at McGill University

His lab focuses on developing and innovating technologies to solve broad questions in pharmacology, with

using innovative approaches, including biosensors, cryo-EM, photoswitchable ligands, and nanobodies as pharmacological

She earned her M.Sc. in Zoology and Neurobiology before completing a Ph.D. in Biology and Pharmacology

Gaetan Guillemette in the Pharmacology department at the Université de Sherbrooke. The pharmacology of latrophilins brings about a great deal of challenges given that they are highly polymorphic

Join us to learn more about chemosensory GPCRs and how computational pharmacology can help better understand

Kari completed her Ph.D. in Pharmacology at Vanderbilt University before continuing her training as a

Work in his independent laboratory is focused on developing new pharmacological tools via chemistry and

will graduate from Duke University this spring with a B.S degree in Biology with a concentration in Pharmacology

Isom was recruited to the Molecular and Cellular Pharmacology Department at the University of Miami Miller School of Medicine in 2016, where he is currently a practicing molecular pharmacologist and biophysicist

on, Paul was hooked and has since studied receptor function in human physiology, receptor molecular pharmacology

Kathryn obtained her BS in Chemistry from Carnegie Mellon University and went on to receive a Ph.D. in Pharmacology

mainly focused on screening and assay development to bridge the gap between in vitro and in vivo GPCR pharmacology

In his (future) independent research career, Aditya aims to work at the interface of GPCR molecular pharmacology

He adapts interdisciplinary approaches (synthesis, modeling, pharmacology) to study G protein-coupled

In April 2009, he joined the Department of Pharmacology and Toxicology at University of Toronto and has

Gutkind is a Distinguished Professor and Chair of the Department of Pharmacology, School of Medicine,

Nicola J Smith is an expert in molecular pharmacology with a track record in exploring GPCR structure-function

Bryan Roth where I established GPCR structural biology and learned the ins and outs of molecular pharmacology

Kase, MD Professor in the Departments of Pharmacological Sciences, Neuroscience, and Artificial Intelligence

Disease Immunology Nervous system Model Organism Phylogenetics and Evolution Aging Basic and Clinical Pharmacology

Specifically, we focus on preclinical evidence of compounds with attractive pharmacological profiles

material that reflects the diverse fields of study encompassing GPCR research, such as biochemistry, pharmacology Their artwork will become the official logo of the GPCR Retreat, featuring prominently on conference

pathway activation Published date July 16, 2024 Abstract "Mathematical models of biochemical reaction networks are an important and emerging tool for the study of cell signaling networks involved in disease processes It is commonly assumed that one must have a thorough characterization of the network readily available study, we first develop a mechanistic mathematical model of a G-protein coupled receptor signaling network

as Cinvestav) in Mexico City, offering a dynamic platform for knowledge exchange, collaboration, and networking Our agenda includes keynote presentations, panel discussions, workshops, and networking sessions covering Network with leading professionals and decision-makers in the industry. Opportunity to sponsor a workshop or networking session. Additional Sponsorship Opportunities: Networking Reception Sponsorship Conference Cup and T-Shirt Sponsorship

Gloriam is a corresponding member of the Nomenclature Committee of the International Union of Pharmacology

Knowledge of the structural dynamics of this complex is limited and pharmacological and in vivo systems characterizing newly generated adhesion GPCR receptors in Drosophila as a model organism for future pharmacological